MLS is officially back and more: Freedom Kicks for 9 July 2020 – Black And Red United

Posted on by

Hello! MLS is officially back, and there was soccer last night and there is soccer right now. It is still a very open question about whether or not these games should be played, but they are here.

To the links:

Recap: Orlando City SC vs. Inter Miami CF 07/09/2020 | Matchcenter

By all accounts, the first game of the MLS is Back Tournament was a scrappy affair, as one would think after such a long layoff. Nani scored the late winner for the hosts.

The Black Players for Change in MLS protest before first MLS Is Back game

However, the most impactful thing from the game was the protest from the Black Players for Change, in which they took the field with the starting lineups to protest police brutality and advocate for human rights.

Roundtable: Leaders of MLSs Black Players for Change on charting a way forward The Athletic

If you want to learn more about the goals of Black Players for Change, I highly recommend that you read this article.

I knew Adidas contract with the league was big, but I didnt know it was that big.

Here is some wholesome Donovan Pines content for your Thursday morning.

There is a new NWSL team, and I really like their color scheme. Pale purple and mint? Yes, please.

Thats all I have this morning, whats up?

Originally posted here:

MLS is officially back and more: Freedom Kicks for 9 July 2020 - Black And Red United

Beefed-up rosters give Cardinals opening to flex versatility, depth of bullpen – STLtoday.com

Posted on by

Cardinals pitcher Kwang Hyun Kim, right, and pitching prospect Johan Oviedo head to the mound during the seventh day of "Summer Camp" at Busch Stadium in St. Louis on Friday, July 10, 2020. Photo by Colter Peterson, cpeterson@post-dispatch.com

Whenever, however he was being used in a game or, in the past few months, throwing bullpens with catcher Yadier Molina in Florida, rookie Junior Fernandez referred to a note he and pitching coach Mike Maddux committed to paper and he committed to using as a compass.

It reminds him regardless of the situation, regardless of the opponent, and regardless of the spot in the game to pitch to his strengths.

Now that Im here Im ready for everything, Fernandez said Friday evening at Busch Stadium. Here you have to be ready for everything any role, any time they call, any time they say youve got to be ready, youve got the next guy. With the plan that I set up, it doesnt matter who I face, doesnt matter what inning I pitch. Im always ready, and I come with the mindset that nobody can hit against me. Pitch with my strengths.

The note gives him direction.

That should help in a shortened season that will start backward and inspire teams to consider reverse-engineering games from the bullpen forward. The 60-game sprint for the postseason starts with a dash of September in July. Rather than end the season with expanded rosters, clubs will begin that way opening with a 30-man roster, as many as 17 pitchers, and handfuls of reasons to go sooner and more often to a deeper bullpen.

Its definitely more backwards than any of us are used to in our game, manager Mike Shildt said. But so are our circumstances. And we adjust and figure it out. I do feel like our ability to understand that weve got a bit more moving parts, with a more abbreviated spring training (makes) sense and literally guys get their legs under them. I feel like our approach is fairly aggressive. With more options, I could see the point of it, allowing for more aggressiveness knowing the next day youre got protection.

Go here to read the rest:

Beefed-up rosters give Cardinals opening to flex versatility, depth of bullpen - STLtoday.com

Hongkongers face a Kafkaesque reality as censors outlaw the words of protest – The Guardian

Posted on by

Writing about the protest movement in Hong Kong, I began to notice the absences everywhere I went. A moving patchwork of white, black and grey squares decorated walls and pavements, as more and more protest slogans were erased from the public gaze. Now, with Beijings enactment of national security legislation in Hong Kong, that void has suddenly gaped wider, swallowing words, ideas, open discussion, and even people from public view.

The legislation bans secession, subversion, terrorism and collusion with foreign forces. The first sight of it for Hongkongers was the moment that it came into effect on Tuesday at 11pm, ahead of the annual 1 July protest march, which itself had been declared illegal.

In one fell swoop, the new law pushed through many of the changes most feared by Hongkongers, by giving mainland legal bodies jurisdiction over some cases inside the territory, allowing the mainland security services to establish offices in the territory, permitting rendition to China and implementing national security education in local schools.

By Thursday night, the government had announced that the most popular protest slogan an eight-character Chinese phrase translating as Liberate Hong Kong, Revolution of our Times violates the legislation as it connotes Hong Kong independence. This phrase has been chanted at every march by almost every attendee. Since that moment, those Chinese characters began disappearing from social media, replaced by initials (GFHG, SDGM), numbers that serve as Cantonese homophones (3639 0242), symbols or geometric representations of the characters. One protest consisted of eight people standing in the street in two groups of four, each holding up a blank piece of paper. In just a few days, those words have already become unspeakable.

By Saturday, Hong Kongs justice secretary, Teresa Cheng, was warning people not to test the national security law by using the slogan. The previous day a 24-year-old man had been charged with inciting secession because his motorbike was adorned with a flag bearing the motto. He was also accused of terrorist acts for driving his bike into a group of policemen.

There are no sources of authority to provide guidance. There are only warnings

Overnight Hong Kongs reality has become Kafkaesque, even Pythonesque, were it not for the real risk of breaking a law that could carry a sentence of life imprisonment. Even the act of alerting Hongkongers to newly illegal acts has become fraught. The government broadcaster, RTHK, used asterisks in its tweets (variously L******* Hong Kong! and Liberate H*** K***!), while the founder of Hong Kong Free Press, Tom Grundy, said he expected legal and bureaucratic terrorism designed to drain the websites resources.

The surrealism was heightened by the police detention of an overjoyed soccer fan suspected of inciting independence after shouting Long live Liverpool! to celebrate the teams Premier League win. He was later released. Among 370 people arrested on 1 July, at least 10 were detained for violating the new legislation, including three women for possessing offensive materials. Among these, it emerged from police photos, was a sticker emblazoned with the word Conscience causing one netizen to comment that in a country without conscience such a sticker surely amounts to secession. The lack of clarity surrounding the offences, combined with such arbitrary application, has left the population dazed. Libraries have already begun pulling books by certain pro-democracy figures from the shelves for review, signalling a looming assault on freedom of information.

In the decade I spent reporting from China, I found that the laws were often less black and white than Id imagined. In covering sensitive stories, we navigated the ambiguity of the shifting grey zone, guided by interviewees who had often spent decades skating on that political thin ice. This is not possible in Hong Kong, where a gigantic black zone has been imposed overnight on what had been a relatively free society. There is no precedent to draw upon, no experts to consult. The fact that no Hong Kong officials not even the chief executive, Carrie Lam had seen the legislation prior to its imposition means there are no sources of authority to provide guidance. There are only warnings.

This law is global in scope, applying to non-residents outside Hong Kong

Fear is the key to its implementation. That fear is real and its working. In the run-up to the laws enactment, some prominent political groups shut down voluntarily. Nathan Law, the territorys youngest lawmaker, who was elected in 2016 and then disqualified on a technicality, announced that he had left Hong Kong.

The national security law compels internet security providers to comply with the authorities requests for information. Now people I know are erasing themselves from view. Facebook pages and Twitter accounts are disappearing, and my phone, which once buzzed incessantly from notifications from Telegram groups, has fallen silent. Friends are asking to move our communications to more secure platforms. Some are even pleading with their contacts to delete all their WhatsApp conversations.

In this digital era when so much of our identity is online, removing your own archive is not just self-censorship, its an act of self-effacement. But many Hongkongers now fear they have no choice but to cancel themselves as an act of survival. This law is global in scope, applying to non-residents outside Hong Kong. This means that any discussion of Hong Kong politics in classrooms, newspapers or parliaments around the world now involves a corollary discussion of risk, particularly if any participants are inside or from Hong Kong.

I wrote a book about the steps taken by Chinas Communist party to erase the collective memory of the Tiananmen Square killings of 4 June 1989, and its success in muting discussion of the anniversary inside China. I never imagined that the party would try to control public discourse inside freewheeling, vibrant Hong Kong. The extraterritorial nature of this legislation poses an assault on language and freedom of speech that is global in nature. To ignore it risks entrenching those absences worldwide.

Louisa Lim is the author of The Peoples Republic of Amnesia: Tiananmen Revisited and a senior lecturer at the University of Melbourne

See the rest here:

Hongkongers face a Kafkaesque reality as censors outlaw the words of protest - The Guardian

Vor bags $110M to move engineered cell therapy into the clinic – FierceBiotech

Posted on by

CAR-T treatments and other immunotherapies have changed the treatment of some blood cancers, but they can target healthy cells as well as cancer cells, causing nasty side effects. Vor Biopharma is working on an engineered stem cell solution, and its raised $110 million to move its lead program into the clinic.

The Cambridge, Massachusetts-based company is developing the treatment, VOR33, for patients with acute myeloid leukemia (AML) whose disease has worsened despite undergoing chemotherapy or a stem cell transplant.

Thats the setting in which a lot of targeted agents are used. The trouble is, a great number of the targeted agents tend to failnot because they are not efficacious, but because the drug is too toxic for the patients bone marrow, Vor CEO Robert Ang told Fierce Biotech.

White Paper: Keep Your GI Trials Moving During COVID-19

Clinical Inks intimate knowledge of and experience with GI trials enables a better deployment experience and improved trial conduct. Learn how our GI-specific data capture solutions can support virtual and hybrid trials during COVID-19.

The drugs home in on healthy cells as well as cancerous ones because they express the same proteins. This leads to myelosuppression, which means the bone marrow doesnt make enough white blood cells, platelets or red blood cells for the patient to survive, Ang said.

RELATED: Neon CBO Robert Ang jumps ship to take the helm at Vor Biopharma

Vors treatment is made from hematopoietic, or blood-forming, stem cells from healthy donors. The company uses gene editing to get rid of cancer drug targets in those cells that are biologically redundant, which means deleting them doesnt cause any harm. That target is CD33, in the case of VOR33.

Were trying to make the marrow treatment resistant such that the only cells that are expressing CD33 should be cancer cells, Ang said. We should be able to target them much more specifically, while minimizing the collateral damage that typically happens with these drugs.

RELATED: 5AM, JJDC get in on $42M series A round for cell therapy player Vor Biopharma

Vor believes its treatments could boost the reach of targeted therapies by improving their efficacy and increasing the amount of time patients can undergo those treatments.

And thats not all. In addition to protecting these transplants and the blood cells they produce from targeted drugs, Vor thinks its approach could change the way we think about bone marrow transplant.

To some degree, transplants have been relatively decentralized and less controlled A lot of hospitals develop their own unique practices as to what they think works and how to handle cells and process them, Ang said. Our product will be regulated by the FDA, so we will be able to provide controls and the proper manufacturing steps to ensure were making the best quality product for patients.

The series B will push VOR33 into clinical trials in the first half of 2021, a target the companys on track to meet despite the COVID-19 pandemic. And Vor plans to expand its portfolio beyond CD33, starting with an umbrella of targets in the myeloid space, namely in acute myeloid leukemia, myelodysplastic syndromes and related diseases.

But we are also looking beyond that to other cancers where there are similar potentially biologically redundant targets we could pursue, said Ang, who took the companys helm in August 2019.

Since then, Vor has grown from a staff of six to 50, and its about to move into new digs in west Cambridge as it moves VOR33 toward the clinic. Its got the backing of RA Capital Management, Fidelity, 5AM Ventures, Johnson & Johnson Innovation, Osage University Partners, PureTech Health, the Pagliuca Family Office and Alexandria Venture Investments to do it all.

Original post:

Vor bags $110M to move engineered cell therapy into the clinic - FierceBiotech

Stem Cell Therapy Market Regulations and Competitive Landscape Outlook – 3rd Watch News

Posted on by

Stem cells are most vital cells found in both humans and non-human animals. Stem cells are also known as centerpiece of regenerative medicine. Regenerative medicines have capability to grow new cells and replace damaged and dead cells. Stem cell is the precursors of all cells in the human body. It has the ability to replicate itself and repair and replace other damaged tissues in the human body. In addition, stem cell based therapies are used in the treatment of several chronic diseases such as cancer and blood disorders.

The global stem cell therapy market is categorized based on various modes of treatment and by therapeutic applications. The treatment segment is further sub-segmented into autologous stem cell therapy and allogeneic stem cell therapy. The application segment includes metabolic diseases, eye diseases, immune system diseases, musculoskeletal disorders, central nervous system disorders, cardiovascular diseases and wounds and injuries.

Request For Report Sample:http://marketgrowthanalysis.com/reports/sample/217

Stem Cell Therapy Market, By Treatments:

Allogeneic Stem Cell TherapyAutologous Stem Cell Therapy

Stem Cell Therapy Market, By End Users:

HospitalsAmbulatory Surgical Centers

Stem Cell Therapy Market, By Application:

OncologyCentral Nervous System DiseasesEye DiseasesMusculoskeletal DiseasesWound & InjuriesMetabolic DisordersCardiovascular DisordersImmune System Disorders

Request For COVID-19 Analysis:http://marketgrowthanalysis.com/reports/enquiry/217

Stem Cell Therapy Market, By Geography:

North AmericaEuropeAsia PacificMiddle East & AfricaLatin America

In terms of geographic, North America dominates the global stem cell therapy market due to increased research activities on stem cells. The U.S. represents the largest market for stem cell therapy followed by Canada in North America. However, Asia is expected to show high growth rates in the next five years in global stem cell therapy market due to increasing population. In addition, increasing government support by providing funds is also supporting in growth of the stem cell therapy market in Asia. China and India are expected to be the fastest growing stem cell therapy markets in Asia.

Key Players in the Stem Cell Therapy Market are:

Chiesi Farmaceutici S.P.A Are:Gamida CellReNeuron Group, plcOsiris Therapeutics, Inc.Stem Cells, Inc.Vericel Corporation.Mesoblast, Ltd.

Request For Report TOC:http://marketgrowthanalysis.com/reports/toc/217

Read this article:

Stem Cell Therapy Market Regulations and Competitive Landscape Outlook - 3rd Watch News

Global Musculoskeletal Disorder Stem Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025 – Daily Research Chronicles

Posted on by

Global Musculoskeletal Disorder Stem Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025 added by Researchstore.biz unveils the current & future growth trends of this business and outlines details regarding the developments of the market. The report analyzes geographies that form a part of the regional spectrum of the global Musculoskeletal Disorder Stem Cell Therapy market. While offering a complete study of the micro and macroeconomic aspects of the market, the report also emphasizes the key driving and restraining forces for this market. The report then sheds light on the supply & demand analysis, contributions by the top players, and market share growth statistics of the industry.

Market Overview:

The report contains an exhaustive analysis of this business space, along with a succinct overview of its various market segments. A basic overview of the Musculoskeletal Disorder Stem Cell Therapy market has been offered with respect to its present position and the industry size, based on revenue and volume. The Global Musculoskeletal Disorder Stem Cell Therapy Market Report has used analytical tools to include accurate research and evaluation data on key industry players and market coverage. Key elements regarding top companies such as their classification, size, profiles, business atmosphere, future, and recent trends, and contact information are featured in the report. Moreover, data concerning growth opportunities for the market across every detailed region is included in the report. The anticipated growth rate expected to be recorded by each region over the estimated years (2020-2025) has also been given within the research report.

DOWNLOAD FREE SAMPLE REPORT: https://www.researchstore.biz/sample-request/34193

NOTE: This report takes into account the current and future impacts of COVID-19 on this industry and offers you an in-dept analysis of Musculoskeletal Disorder Stem Cell Therapy market.

The report investigates the development, trends, and new entrants in the sector, with elaborate profiles of the leading companies operating in the market, including: Osiris Therapeutics , Medi-post , NuVasive , Takeda (TiGenix)

In market segmentation by types, the report covers: Allogeneic, Autologous

In market segmentation by applications, the report covers the following uses: Muscle disease, Skeletal disease

Providing a brief of the regional landscape:

Regional segmentation: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East& Africa (Saudi Arabia, UAE, Egypt and South Africa)

Moreover, the report talks about the production aspect, product remuneration, the gross margins of the firms manufacturing the product, and the manufacturing of the product. The report includes information about the product consumption volume and the product consumption value has also been given in the global Musculoskeletal Disorder Stem Cell Therapy report. It delivers a detailed understanding of the consumption patterns of the product.

ACCESS FULL REPORT: https://www.researchstore.biz/report/global-musculoskeletal-disorder-stem-cell-therapy-market-34193

Some Concepts And Ideas Discerned In The Report:

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Researchstore.biz is a fully dedicated global market research agency providing thorough quantitative and qualitative analysis of extensive market research.Our corporate is identified by recognition and enthusiasm for what it offers, which unites its staff across the world.We are desired market researchers proving a reliable source of extensive market analysis on which readers can rely on. Our research team consist of some of the best market researchers, sector and analysis executives in the nation, because of which Researchstore.biz is considered as one of the most vigorous market research enterprises. Researchstore.biz finds perfect solutions according to the requirements of research with considerations of content and methods. Unique and out of the box technologies, techniques and solutions are implemented all through the research reports.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.researchstore.biz

Browse Related Report :

Global Somatostatin Market 2020 Segmentation, Statistics, Top Manufacturers, Regional Analysis and Forecast to 2025Global Behentrimonium Methosulfate Market 2020 Growth Drivers, Regional Outlook, Competitive Strategies and Forecast up to 2025Global Infant Incubator Market 2020 Development Analysis, Strategic Outlook, Growth Rate and Forecast to 2025Global Glacial Acrylic Acid Market 2020 Ongoing Trend, Recent Developments, Competitive Landscape and Regional Forecast to 2025Global Welding Robot Market 2020 Manufacturer Analysis, Technology Advancements, Industry Scope and Forecast to 2025

The rest is here:

Global Musculoskeletal Disorder Stem Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025 - Daily Research Chronicles

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Professional Survey Report 2026: By Product, Application, Manufacturer, Sales and…

Posted on by

The Global Autologous Stem Cell and Non-Stem Cell Based Therapies Marketplace gives detailed Evaluation about all of the Important aspects regarding the marketplace. The analysis on Global Autologous Stem Cell and Non-Stem Cell Based Therapies economy, offers profound insights regarding the Autologous Stem Cell and Non-Stem Cell Based Therapies marketplace covering all of the significant characteristics of the marketplace. In addition, the report offers historical information with prospective prediction over the forecast period. Various critical aspects like market trends, earnings development patterns market stocks and supply and demand are contained in practically all of the market research document for every single business. A number of the vital facets analysed in the report contains market share, creation, key areas, earnings rate in addition to key players.

The analysis of different sections of the Global Autologous Stem Cell and Non-Stem Cell Based Therapies market are also Covered in the study report. Along with this, for the prediction periods conclusion of variables such as market size and the competitive landscape of this sector is assessed in the report. On account of the rising globalization and digitization, there are new tendencies coming to the marketplace daily. The study report provides the detailed analysis of all of these tendencies.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2632388&source=atm

Additionally, the Autologous Stem Cell and Non-Stem Cell Based Therapies marketplace report also supplies the Latest tendencies in the Global Autologous Stem Cell and Non-Stem Cell Based Therapies marketplace with the assistance of primary in addition to secondary research methods. Also, the analysis report on Autologous Stem Cell and Non-Stem Cell Based Therapies marketplace gives a wide evaluation of the marketplace including market review, manufacturing, manufacturers, dimensions, cost, value, growth rate, earnings, prices, export, consumption, and sales revenue of this Global Autologous Stem Cell and Non-Stem Cell Based Therapies market. On the flip side, the Autologous Stem Cell and Non-Stem Cell Based Therapies marketplace report also studies the industry standing for the prediction period. Nevertheless, this can help to grow the advertising opportunities throughout the world in addition to major market suppliers.

The key players covered in this studyFibrocell Science, Inc.Vericel CorporationDendreon Corporation (Sanpower Group)Caladrius Biosciences, Inc.BrainStorm Cell TherapeuticsRegeneus Ltd.Genzyme CorporationPluristem Therapeutics IncU.S. Stem Cell, IncTiGenix (Takeda)

Market segment by Type, the product can be split intoAutologous Stem Cell TherapyNon-Stem Cell TherapyMarket segment by Application, split intoCancerNeurodegenerative DisordersCardiovascular DiseaseAutoimmune DiseasesOthers

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanMid East & AfricaAustralia

The study objectives of this report are:To analyze global Autologous Stem Cell and Non-Stem Cell Based Therapies status, future forecast, growth opportunity, key market and key players.To present the Autologous Stem Cell and Non-Stem Cell Based Therapies development in North America, Europe, China, Japan, Mid East & Africa and Australia.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Autologous Stem Cell and Non-Stem Cell Based Therapies are as follows:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2632388&source=atm

The Autologous Stem Cell and Non-Stem Cell Based Therapies market report provides useful insights for Every established and advanced players throughout the world. Additionally the Autologous Stem Cell and Non-Stem Cell Based Therapies marketplace report provides accurate evaluation for the changing competitive dynamics. This study report includes a whole analysis of future expansion concerning the evaluation of this mentioned prediction interval. The Autologous Stem Cell and Non-Stem Cell Based Therapies marketplace report provides a thorough analysis of the technological advancement prognosis over time to be aware of the industry growth prices. The Autologous Stem Cell and Non-Stem Cell Based Therapies marketplace report also has innovative analysis of the massive number of unique facets which are fostering or functioning in addition to regulating the Autologous Stem Cell and Non-Stem Cell Based Therapies marketplace development.

A systematized methodology can be utilized to create a Study on the Global Autologous Stem Cell and Non-Stem Cell Based Therapies Sector. For the research of economy on the Conditions of study Approaches, these strategies are useful. All of the Information Regarding this Products, makers, vendors, clients and even more is covered in research reports. Various important factors like market trends, earnings Growth patterns market stocks and supply and demand are contained in virtually all The market study report for every single business. Adaptation of fresh thoughts and Accepting the most recent tendencies are a few the causes of virtually any markets growth. The Global Autologous Stem Cell and Non-Stem Cell Based Therapies market research report provides the profound understanding concerning the Areas in which the marketplace is impactful.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2632388&licType=S&source=atm

Read more:

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Professional Survey Report 2026: By Product, Application, Manufacturer, Sales and...

Global Autologous Cell Therapy Market Revenue Outcome, Robust Vendors, and Investment Prospects – 3rd Watch News

Posted on by

Market Research Exploreoffers an exhaustive analysis on the Global Autologous Cell Therapy Market covering diverse significant factors that pose an impact on the current and forthcoming market conditions. The report elaborates on how the Autologous Cell Therapy market has been performing over the last five years at the global and regional levels. It also analyzes expected ups and downs in the market over the next five years. The report assists market players to operate their business wisely. Market scope, establishment, profitability, maturity, and growth prospects are also highlighted in the global Autologous Cell Therapy market report.

The report mainly emphasizes the market rivalry landscape, leading players profiles, segmentation, and industry environments which have been playing an integral role in posing impacts on market structure and profitability. It also includes a precise assessment of market share, size, demand, production, sales, and revenue that help intuit the financial health of the industry. It also illuminates various market dynamics such as changing product values, demand-supply variations, contemporary trends, pricing fluctuations, growth-driving forces, and unstable market conditions.

Sample Copy Global Autologous Cell Therapy Market Report 2020:https://www.marketresearchexplore.com/report/global-autologous-cell-therapy-industry-market-research-report/174131#enquiry

Extensive study of crucial Autologous Cell Therapy market segments:

The global Autologous Cell Therapy market has been segmented into a number of various vital segments such as types, applications, and regions. The report evaluates each segment at a minute level in view of its growth prospects, global demand, and current revenue. It also focuses on the segments that are exhibiting exponential growth during the year and help market players in selecting more profitable segments for their Autologous Cell Therapy businesses and precisely determine the actual needs and wants of their customer base.

Global Autologous Cell Therapy Market Competitive Assessment:

Expansive survey of Global Autologous Cell Therapy Market 2020

According to the report findings, the global Autologous Cell Therapy market report is extremely competitive and encouraging leading manufacturers and companies to execute various business and marketing strategies such as M&A activities, brand promotions, product launches, partnerships, and other expansions to perform comfortably in the relentless competition. The report further examines highlights new product developments, innovations, and technology adoptions done by the competitors in order to offer upgraded products and services in the global Autologous Cell Therapy market.

The report also provides a detailed financial assessment of leading market vendors and insights into the competencies and capacities of these companies to assist Autologous Cell Therapy market players for business expansions. The report also deeply analyzes effective product lines offered by various manufacturers and helps other participants to boost the quality of their products. Analysis based on forthcoming challenges and opportunities is also highlighted in the report, which will help Autologous Cell Therapy market players build lucrative strategies and grab all growth opportunities.

Significant Features of the Global Autologous Cell Therapy Market Report:

Connect with our industry experts at[emailprotected].

More here:

Global Autologous Cell Therapy Market Revenue Outcome, Robust Vendors, and Investment Prospects - 3rd Watch News

Stem Cell Therapy Market Outlook, Opportunity, Demand Analysis And Forecast 2020 2026 – Owned

Posted on by

New Jersey, United States,- Latest update on Stem Cell Therapy Market Analysis report published with extensive market research, Stem Cell Therapy Market growth analysis, and forecast by 2026. this report is highly predictive as it holds the overall market analysis of topmost companies into the Stem Cell Therapy industry. With the classified Stem Cell Therapy market research based on various growing regions, this report provides leading players portfolio along with sales, growth, market share, and so on.

The research report of the Stem Cell Therapy market is predicted to accrue a significant remuneration portfolio by the end of the predicted time period. It includes parameters with respect to the Stem Cell Therapy market dynamics incorporating varied driving forces affecting the commercialization graph of this business vertical and risks prevailing in the sphere. In addition, it also speaks about the Stem Cell Therapy Market growth opportunities in the industry.

Stem Cell Therapy Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including Stem Cell Therapy market size, volume and value, as well as price data.

Stem Cell Therapy Market competition by top Manufacturers:

Stem Cell Therapy Market Classification by Types:

Bytype1

Stem Cell Therapy Market Size by End-user Application:

Byapplication1

Listing a few pointers from the report:

Objective of Stem Cell Therapy Market Report:

Cataloging the competitive terrain of the Stem Cell Therapy market:

Unveiling the geographical penetration of the Stem Cell Therapy market:

The report of the Stem Cell Therapy market is an in-depth analysis of the business vertical projected to record a commendable annual growth rate over the estimated time period. It also comprises of a precise evaluation of the dynamics related to this marketplace. The purpose of the Stem Cell Therapy Market report is to provide important information related to the industry deliverables such as market size, valuation forecast, sales volume, etc.

Major Highlights from Table of contents are listed below for quick look up into Stem Cell Therapy Market report

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email: [emailprotected]arketresearch.com

Our Trending Reports

Metabolomics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Stem Cell Therapy Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Influenza Diagnostics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Biomarkers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

3D Bioprinting Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

The rest is here:

Stem Cell Therapy Market Outlook, Opportunity, Demand Analysis And Forecast 2020 2026 - Owned

COVID-19 Impact and Recovery Analysis on Cell Freezing Media for Cell Therapy Market 2020-2026 by BioLife Solutions, Akron Biotechnology, GE…

Posted on by

Heres recently issued report on the Global Cell Freezing Media for Cell Therapy Market that allows you to offer a brief analysis of the market size, demand, supply chain, distribution channels, futuristic trends, market growth elements and so on. It offers a comprehensive analysis of assorted business aspects like global Cell Freezing Media for Cell Therapy market trends, recent technological advancements, market shares, size and new innovations. What is more, this analytical knowledge has been compiled through knowledge searching techniques like primary and secondary analysis for Cell Freezing Media for Cell Therapy industry. Moreover, an professional team of researchers throws lightweight on numerous static additionally as dynamic aspects of the worldwide Cell Freezing Media for Cell Therapy market.

NOTE: Our reports include the analysis of the impact of COVID-19 on this industry. Our new sample is updated which correspond in new report showing impact of Covid-19 on Industry trends. Also we are offering 20% discount

Obtain sample copy of Cell Freezing Media for Cell Therapy market report: https://calibreresearch.com/report/global-cell-freezing-media-therapy-market-5285#request-sample

Geographically, the worldwide Cell Freezing Media for Cell Therapy market has been analyzed in numerous regions like North America, geographical region, geographical region, Asia-Pacific, Africa, Europe and Asian nation. The worldwide Cell Freezing Media for Cell Therapy market region is dominating this market among the forthcoming future. Worldwide Cell Freezing Media for Cell Therapy market is that the skilled and correct study of assorted business views like key players, key geographies, divers, restraints, opportunities and challenges. This global analysis report has been mass on the concept of assorted market segments and sub-segments associated with the worldwide market.

Global Cell Freezing Media for Cell Therapy market competition by prime manufacturers, with Cell Freezing Media for Cell Therapy sales volume, value (USD/Unit), revenue (Million USD) and market share for each manufacturer. The report provides an in-depth analysis of the worldwide Cell Freezing Media for Cell Therapy Market progressing to cut back time to plug for products and services, cut back operational value, improve accuracy and operational performance. Besides this, the report elaborates crucial aspects such as fresh product establishment, greater expenditure in R&D and increasing demand in the manufacturing differentiable growth opportunities in the Cell Freezing Media for Cell Therapy Market globally.

Checkout Inquiry For Buying or Customization of Cell Freezing Media for Cell Therapy Market Report: https://calibreresearch.com/report/global-cell-freezing-media-therapy-market-5285#inquiry-for-buying

The complete profile of the manufacturers are mentioned. And so the capability, production, price, revenue, cost, gross, margin of profit, sales volume, sales revenue, consumption, rate of growth, import and export, future strategies and therefore the technological developments that they are creating are also enclosed among the report. The historical knowledge and forecast knowledge from 2020 to 2026.

Leading companies reviewed in the Cell Freezing Media for Cell Therapy report are:

BioLife SolutionsAkron BiotechnologyGE HealthcareThermo Fisher ScientificBiological IndustriesMerckWAK-Chemie MedicalZenoaq

The Cell Freezing Media for Cell Therapy Market report is segmented into following categories:

The Cell Freezing Media for Cell Therapy market report is segmented into Type by following categories;With FBSWithout FBS

The Cell Freezing Media for Cell Therapy market report is segmented into Application by following categories;Human Embryonic Stem CellsCAR-T Cell TherapyNeural Stem Cell TherapyMesenchymal Stem Cell TherapyHematopoietic Stem Cell TransplantationOther

Checkout FREE Report Sample of Cell Freezing Media for Cell Therapy Market Report for Better Understanding: https://calibreresearch.com/report/global-cell-freezing-media-therapy-market-5285#request-sample

The report provides substantial knowledge relating to the market share that every one in every of these firms presently garner across this business, in tandem with the market share that they are expected to amass by the highest of the forecast period. Also, the report elaborates on details regarding the products manufactured by every of these companies, that may facilitate new entrants and outstanding stakeholders work on their competition and strategy portfolios. To not mention, their decision-making method is vulnerable to get easier on account of the actual fact that the Cell Freezing Media for Cell Therapy System market report additionally enumerates a gist of the products value trends and so the profit margins of each firm among the industry.

This will enable the readers to focus on Cell Freezing Media for Cell Therapy market product specifications, current competitive manufacturers in Cell Freezing Media for Cell Therapy market and also the market revenue with gain. Worldwide Industry Analyze Cell Freezing Media for Cell Therapy Market by competitive manufacturers, regions and applications of Cell Freezing Media for Cell Therapy market, forecast up to 2026. This report analyses the scope of Cell Freezing Media for Cell Therapy market. This will be achieved by Cell Freezing Media for Cell Therapy previous historical information, analysing qualitative insights info, demonstrable projections regarding global Cell Freezing Media for Cell Therapy market size.

Here is the original post:

COVID-19 Impact and Recovery Analysis on Cell Freezing Media for Cell Therapy Market 2020-2026 by BioLife Solutions, Akron Biotechnology, GE...

13 promising Covid-19 treatments emerging from Israel – The Yucatan Times

Posted on by

In parallel to vaccine research, theres an urgent need for effective treatments for the respiratory disease caused by the SARS-CoV-2 coronavirus.

ISRAEL (Scientists across the globe are working on vaccines to prevent Covid-19 infection. After initial vaccines are approved, there is an urgent need for effective treatments for the respiratory disease caused by the SARS-CoV-2 coronavirus.

Most potential treatments target the life-threatening lung inflammation typical of covid-19 severe cases. Its caused by a phenomenon called a cytokine storm.

Cytokines are proteins that trigger inflammation as a natural response to infection. In response to a virus overload, in this case, in the lungs, the immune system activates a storm of cytokines. Too many cytokines lead to too much inflammation, which can damage the lungs and cause respiratory distress.

Israeli hospitals were among the first anywhere to use dexamethasone, a steroid drug, to stop cytokines storms and reduce lung inflammation in severely ill Covid-19 patients. However, steroids can suppress the immune response too actively.

Additionally, an Israeli hospital is among the first to do a randomized, double-blind, placebo-controlled clinical trial of ivermectin, a drug to treat parasitic infections in people and animals, to see if it can shorten the duration of the disease if given to Covid-19 patients immediately after diagnosis.

Israelis are also formulating novel therapeutics of their own. Here are 13 potential Israeli treatments using a variety of approaches.

PluristemOn June 11, Pluristem Therapeutics of Haifa announced a multicenter Phase 2 US Food and Drug Administration (FDA) efficacy and safety study of its PLX-PAD cells for treating severe Covid-19 complicated by acute respiratory distress syndrome (ARDS).

PLX, an injected regenerative placenta-derived cell therapy, stimulates the immune systems natural regulatory T cells and M2 macrophages, possibly preventing or reversing a cytokine storm. PLX cells potentially reduce the incidence or severity of Covid-19 pneumonia and pneumonitis.

Pluristem has treated Covid-19 patients under compassionate use programs in the United States and Israel. Initial data from 18 patients showed that 75% were off mechanical ventilation within 28 days.

PLX cells are available off-the-shelf and once commercialized, can be manufactured in large-scale quantities, offering a key advantage in addressing a global pandemic, the company said.

SilkimJerusalem-based Silkim Pharma recently submitted Coronzot, its novel treatment for Covid-19 patients with moderate to severe symptoms, to the FDAs Investigational New Drug (IND) program.

IND designation would give Silkim permission to start human clinical trials and ship Coronzot across state lines before a marketing application has been approved.

Coronzots novel mechanism targets a pivotal factor in cytokine storms. It removes an inflammatory overaccumulation of labile iron and replaces it with a minute amount of gallium or zinc.

This not only suppresses the storm but also inhibits viral proteins that attack the lungs and heart. Gallium inhibits virus replication and promotes apoptosis (self-destruction) of already invaded cells. Zinc helps suppress inflammatory reactions and enzymes that enable coronavirus replication.

The company is actively engaged in the FDA process. We look forward to finalizing the IND and then moving towards conducting clinical studies of Coronzot for Covid-19, said Silkim Pharma CEO Dror Chevion.

RedHill BiopharmaRedHill Biopharma, based in Raleigh, North Carolina, and Tel Aviv, is racing to advance our development program with opaganib for Covid-19, according to a June 10 statement by Dr. Mark L. Levitt, RedHill medical director.

RedHill acquired opaganib from US-based Apogee Biotechnology, which developed this oral drug to fight cancer, inflammation, and viruses.

RedHill has seen encouraging preliminary findings from six Israeli Covid-19 patients given opaganib under compassionate use to reduce lung inflammation. All were weaned from supplemental oxygen and discharged from the hospital without having to receive mechanical ventilation.

RedHill plans a multicenter, randomized, double-blind, parallel-arm, placebo-controlled Phase 2/3 clinical study on 270 US patients with severe Covid-19 pneumonia.

We are expanding the development program to Russia and additional European countries, parallel with the US clinical study, to accelerate the collection of robust data on the potential efficacy of opaganib against Covid-19, said Levitt.

The company is working with government agencies worldwide to allow more patients access to the investigational drug through clinical studies and compassionate use programs.

InnoCanInnoCan founders, from left, Ron Mayron, Iris Bincovich, Yoram Drucker. Photo by Rotem LahavInnoCan Pharma Israel and Tel Aviv University tech-transfer company Ramot are collaborating to develop a new CBD-loaded exosome technology to fight lung inflammation.

Exosomes, small particles created from stem cells, can act as homing missiles targeting specific damaged organs and facilitating cell-to-cell communication.

Combining the cell-healing properties of exosomes with the anti-inflammatory properties of the cannabis-derived compound CBD is expected to have a strong synergetic effect. The treatment is administrated by inhalation.

Stero BiotechsStero Biotechs of Bnei Brak has started a small clinical trial at Rabin Medical Center in Petah Tikva on the tolerability, safety, and efficacy of CBD-enhanced steroid treatment for hospitalized Covid-19 patients.

Steroid treatment is usually the first or second line of treatment for hospitalized patients. CBD enhances the therapeutic effect of steroid treatment and treats the bio-mechanism affected by the virus, the company explained.

Eybna and CannaSoulTwo Israeli cannabis R & D firms, Eybna Technologies and CannaSoul Analytics, develop a proprietary terpene formulation for modulating cytokine storms.

Terpenes are organic compounds found in cannabis and other plants. Studies suggest they can be effective antiviral agents.

CannaSouls Cytokine Storm Assay (from its Myplant-Bio subsidiary) will aid in optimizing and customizing Eybnas novel NT-VRL inhaled formulation for treatment and prevention of viral infections in high-risk populations and actively ill patients.

The FDA considers this assay as a good predictor for cytokine storm response and immunotoxicity, and it is commonly required in the development of biological treatments, according to CannaSoul Chairman and CSO Prof. Dedi Meiri.

The NT-VRL formulation intended to be used via inhalation, said Eybna CEO Nadav Eyal. This delivery method dramatically increases the terpenes bioavailability by directly contacting the infected cells in the respiratory system.

CannaSoul aims to identify other cannabis molecules capable of suppressing a cytokine storm in response to Covid-19 without completely suppressing the immune system. It is also studying how cannabis molecules could modulate the ACE2 receptor, which allows the virus to inject its genetic expression into human cells.

KamadaBased in Rehovot, Kamada has begun supplying its experimental plasma-derived Hyperimmune IgG therapy for compassionate use in severe Covid-19 cases in Israel.

The treatment is based on plasma donated by recovered Israeli Covid-19 patients. One critically ill patient at Hadassah Medical Center showed initial improvement after having the experimental IgG therapy but ultimately did not survive.

During the third quarter of this year, Kamada expects to start a Phase 1/2 clinical study in hospitalized Covid-19 patients in Israel and hold a pre-IND meeting with the FDA to expand clinical development in the United States in partnership with Kedrion Biopharma.

Kedrion is collecting plasma from recovered American Covid-19 patients at 23 FDA-approved centers across the United States. This will be used by Kamada to manufacture additional batches of the product.

To the best of our knowledge, Kamada is the first company globally to complete manufacturing of a plasma-derived IgG product for the treatment of Covid-19, said Kamada CEO Amir London.

Israel Institute for Biological ResearchThe government-run Israel Institute for Biological Research (IIBR) announced in May that analogs of two drugs for Gauchers disease proved effective against SARS-CoV-2.

This drug cocktail is made up of the FDA-approved Cerdelga and an analog of the second drug in advanced stages of the approval process.

The IIBR study on cell cultures demonstrated that the two-drug treatment significantly reduced the coronaviruss replication capacity and the destruction of the infected cell. This potential treatment is currently being tested in animals infected with the coronavirus.

The IIRB also isolated several critical coronavirus antibodies that successfully neutralized aggressive coronavirus in lab tests. These could form the basis of future treatment following further testing.

PepticomBased in Jerusalem, Pepticom computationally designs novel peptide drug candidates using artificial intelligence. The company raised $5 million last year.

Three months ago, Pepticom began implementing its proprietary AI technology on various coronavirus proteins to identify novel peptides that inhibit the interaction between the spike protein of SARS-Cov-2 and the ACE2 receptor thereby stopping the virus from entering the cell.

CEO Immanuel Lerner says three such proteins have already been identified and are being validated in the lab.

Using AI is a fast way to find these peptides, which are less expensive and easier to produce than antibodies, Lerner tells ISRAEL21c. Many parties are interested in looking at our results and finding ways to develop this further.

Bonus BioGroupIn April, Bonus BioGroup initiated a preclinical study of MesenCure, its unique drug for treating acute and life-threatening respiratory distress in coronavirus and pneumonia patients.

MesenCure consists of activated mesenchymal stromal (stem) cells from healthy adult donors. The activation of these MSCs is intended to boost their ability to reduce lung inflammation, promote regeneration of the diseased lung tissue, and alleviate respiratory and other symptoms in the lungs.

The development of MesenCure relies on more than a decade of related experience and technologies that Bonus BioGroup has used in developing its lead product, a tissue-engineered bone graft, also based on MSCs.

With the current coronavirus outbreak, Bonus BioGroup has started tissue culture studies into the potential of these MSCs, further activated, to alleviate inflammation, including in the lungs, and possibly attenuate the cytokine storm in COVID-19 patients, the company explained.

The preclinical study in several animal models is expected to be completed in the third quarter of 2020. The company said preliminary results indicate that following the treatment with MesenCure, the microscopic appearance of the treated lungs was similar to a healthy lung, and a significant improvement in additional related parameters was achieved.

Bonus BioGroup presented these results to 1,800 scientists, physicians, and public opinion leaders at the International Society for Cell & Gene Therapy virtual conference in May.

NanoGhostTechnion-Israel Institute of Technology Prof. Marcelle Machluf developed a drug-delivery technology that uses reconstructed mesenchymal stem cells as nano-vesicles to transport medicine directly to a target.

NanoGhost is the startup she established to commercialize the technology, which has proven successful in treating pancreatic, lung, breast, prostate, and brain cancer in mice. The NanoGhost technology has been patented in the United States and Europe, with additional patents pending in India and China.

Now, Machluf is adapting her technology to create decoy NanoGhosts that attract and entrap the coronavirus, making for a less severe infection. She explains it in the video below.

EnlivexEnlivex Therapeutics of Ness Ziona is developing Allocetra, a novel immunotherapy medication to treat organ dysfunction and acute multiple organ failure associated with sepsis and Covid-19, as well as solid tumors.

Allocetra rebalances a severely unbalanced immune system by engaging with the immune systems own regulation mechanisms. It is designed to restore a safe immune balance following a cytokine storm.

Enlivex is starting to recruit Covid-19 patients in Israel and in the United States to test the potential effect of Allocetra on moderate to severe cases. A patent from the Japan Patent Office is expected during the third quarter of 2020.

Weizmann Institute of ScienceOrganic chemist Nir London of the Weizmann Institute of Science in Rehovot is co-leading a collaborative project to identify small molecules that can bind to and inhibit a protease enzyme that the SARS-CoV-2 virus needs to reproduce.

London and his research team had previously developed an advanced method for identifying potential inhibitors for numerous proteins.

So far, we have made close to 800 compounds and tested more than 650 and keep getting closer to sufficiently potent inhibitors, London tells ISRAEL21c.

These inhibitors will be further investigated for their potential as a starting point for new drugs against the coronavirus.

London is working with researchers from Oxford University, Memorial Sloan Kettering Cancer Center, University of British Columbia, and Californian-based biotech company.

The Yucatan TimesNewsroom

comments

View original post here:

13 promising Covid-19 treatments emerging from Israel - The Yucatan Times

Rowdy Teens Prompt Curfew In Toms River Beach Communities – Toms River, NJ Patch

Posted on by

TOMS RIVER, NJ Beginning Thursday night, kids under the age of 18 will have to be off the streets in Toms River's barrier island beach communities from 9 p.m. to 5 a.m. under an order issued by the Toms River authorities.

The curfew has been instituted in response to continuing problems with kids gathering in large groups in those communities and vandalizing property and causing other problems, said Jillian Messina, media relations specialist with the Toms River Police Department.

"Residents have reported increasing problems with unruly juveniles congregating nightly in violation of the social distancing and face mask restrictions imposed by the governor's executive order, and also committing acts of criminal mischief and other disorderly behavior," Messina said, quoting an emergency order issued by the township's Office of Emergency Management and the police department.

The incidents have been happening in the North Beach area on the barrier island, which includes Silver Beach, Monterey, Normandy Beach, Chadwick Beach and Ocean Beaches 1, 2 and 3.

The incidents have been happening since early June, Messina said, and have continued despite warnings from the police department for parents to not drop off kids at random in the communities. Read more: Keep Kids Home, Toms River Police Warn, After Property Damage

"While we understand these are difficult times and children are frustrated with the lack of open activities, it is not an excuse for misbehavior and disrespect within our community," Messina said.

The curfew prohibits anyone 17 or younger from being on "a public street, avenue, boulevard, place, walkway, alley, park, or any public area or unimproved private property located in the North Beach area of the Township between 9 p.m. and 5 a.m., unless accompanied by a parent or legal guardian," according to the order.

Messina said the goal has been "to educate our community, especially parents."

Kids who are out in violation fo the curfew will be told to go home, she said. Those who refuse to follow the curfew "may be taken into protective custody and returned to their homes with charges pending.

"When violations are egregious, they may be taken into custody and brought to headquarters where complaints will be signed and a parent or a guardian will have to respond to pick them up after processing," she said.

Originally posted here:

Rowdy Teens Prompt Curfew In Toms River Beach Communities - Toms River, NJ Patch

Mass publishing has a history of coping with pandemics. After all, it was born of one – Scroll.in

Posted on by

In October 1347, a fleet of trading ships docked at the Sicilian port of Messina. People gathered on the docks were in for a nasty surprise when they went on board. Most of the sailors aboard the ships were dead. Those still alive were mysteriously ill and covered in black boils that oozed blood and pus. Aghast, Sicilian authorities hastily ordered the death ships out of the harbour and back to their origins in the Black Sea, but it was too late.

Over the next five years, the Black Death (more mundanely known as the bubonic plague) would dart across Europe, leaving a trail of death in its wake and wiping out almost one-third of the continents population. It didnt entirely disappear until the beginning of the seventeenth century. And yet, despite its murderous effect, the Black Death was the making of modern Europe.

It played a central role in the advent of new population controls, in the establishment of universities, the spread of Christianity, the dissemination of vernacular culture, and even the rise of nationalism. In Italy alone, the Black Death marked the end of an era and the emergence of the Renaissance: that golden period of art, architecture and literature in human history.

Pulling this new narrative in politics, religion and socio-economic change together was a common thread, spun by the hand of a German goldsmith named Johannes Gutenberg. The story of Gutenberg and his printing press, and the veritable revolution of ideas it caused in the 1400s, not just across Europe, but across the world is one that most of us know. Within decades, the worlds nascent publishing industry had accommodated itself to the new world and to a new class of readers.

Initial books were copied in long-form, manuscript style, to initiate the new reader slowly. Paper went from being manufactured from sheepskin (parchment) or calfskin (vellum) to being made out of leftover rags, slashing its costs in half. In the 1480s, a savvy Venetian printer by the name of Andre Manutius decided to compress the size of an average book giving birth to the 15th centurys version of the modern e-book, the pocket book. By 1604, to cope with the increasing complexities of social, economic and political upheaval, the first weekly newspapers (then quaintly called news-books) came into being in Europe.

The Black Death was not the first pandemic in the world, nor would it be the last. Regular outbreaks of disease across the globe have felled people in their scores, but they have not surprisingly slowed or extinguished the publishing industry. In his excellent account of the Black Death, the historian Philip Ziegler writes, Painful readjustment, demoralisation, lawlessness: such are the familiar symptoms of a society recovering from the shock of the plague.

While this is undeniably true, a glance across the pages of history informs the curious that despite death, loss and unspeakable fear, the human mind has never lost its quest to learn. Publishing houses across the ages have stood as testament to this fact. In 1534, King Henry VIII established Cambridge University Press, giving it carte blanche to print any manner of books.

The Press still stands today, with the distinction of being the worlds oldest publishing house. It has weathered technological changes, two global wars, repeated pandemics from recurrences of the plague to the Spanish flu, from the Asian flu to Ebola and H1N1 and social and economic turmoil to continue producing not just religious texts, but also academic tracts spanning a wide range of subjects.

Theirs is just one example of the hundreds of publishing houses that sprang up in the wake of Gutenbergs press. By 1482, there were 100 printing presses in Europe alone. By 1500, about 40,000 different editions were circulating in the European market, which came up to a total of 6,000,000 copies in print. It wasnt long before the press had found its way to other continents, revolutionising the way people thought.

In 1556, a Portuguese ship docked in Goa, India. Aboard were 14 Jesuit priests bound for Abyssinia (Ethiopia on todays map), and a printing press. The press made landfall in India after the awed clergy in Goa made the impassioned plea that they needed it more than the Abyssinians. It didnt catch on, however, until 1706 when the Dutch reached India. A missionary with the awe-inspiring name of Bartholomew Zeigenbalg insisted that for his work, he needed the printing press. And so it was that the first printing press began functioning in Tharangambadi (Tranquebar) in Madras.

Todays testament to this historic moment is the Tranquebar imprint, owned by Westland Books in India. Now, it wasnt to be expected that this delightful new medium of disseminating information and making some money would function in a void. The next step, quite obviously, were bookshops. The explosion of printing presses and the resultant flood of books and information into an eager market was fertile soil for anyone wanting to trade in books.

In 1887, Elkin Mathews and John Lane set up The Bodley Head, to trade in antiquarian books in London. The bookshop survived the Great War and in 1919, it was taken over by Lanes nephew, Allen. Lanes ideas were dynamic enough to terrify the staid board of directors at The Bodley Head. Against the backdrop of the Great War, and another pandemic this time, the deadly Spanish flu Allen Lane pushed for the expansion of The Bodley Head into newer, more dynamic realms of publishing fiction, for instance. Part of his enthusiasm came from the remarkable momentum in publishing across the Channel, and part from the United States of America.

The United States had been hit badly by the Spanish flu. Nearly 50 million people had died across the country by the time the pandemic petered out, but as people grappled with questions of life and death, and larger, more political ideas such as fascism and imperialism, literature became a chosen outlet. In 1914, as the world went to war, Margaret Anderson began The Little Review.

It was supposed to be a literary journal, carrying poetry and prose themed around feminism and anarchism. But in the fifteen years that it ran (it finally ended its print run in 1929), The Little Review stood as an example to prove that events of catastrophic import a war, say, or a pandemic were hard drivers for both increased learning and the kind of change that a society sought at that moment in time.

Andersons key aides were Jane Heap, her business partner, publisher and lover, and the critic and poet Ezra Pound. Between the three of them, they built The Little Review into one of modern literatures most controversial and elite platforms. Everyone from Ernest Hemingway to TS Eliot and WB Yeats was published in The Little Review, which once daringly brought out an entirely blank issue, to condemn the lack of exciting new literature to review and critique. Yet another example of how publishing has, in its own way, been a beacon for the kind of revolution that society has sought from time to time.

Between 1918 and 1920, The Little Review serialised James Joyces Ulysses, with the final episode ending on Joyces 40th birthday. The world may have been reeling with a virus nobody could understand, but it still appreciated good story-telling. So much so that it caught the eye of a young woman in Paris.

Sylvia Beach her real name was Nancy Woodbridge Beach was a young student of French contemporary literature in Paris, when she met the woman who would become her lover and the inspiration for the iconic Shakespeare and Company. The bookshop was set up in November 1919, and soon became the celebrated haunt of writers like F Scott Fitzgerald, Mina Loy and Gertrude Stein. In 1922, Beach scandalised and tantalised Parisian society by publishing Ulysses.

Her avant-garde attitude to life and literature charmed Allen Lane. By the end of the Great War, the Spanish flu had appeared in Britain as well. Lane insisted that The Bodley Head step away from its specialty trade of antiquarian books into newer waters. Penguin Books would become Lanes new imprint, and under its emblem, James Joyces saga found a home in England. There was no looking back for Lane and his newborn publishing house after that, which became a monolith in the publishing industry in the twentieth century.

Allen Lane wasnt the only one who foresaw a future in publishing. There were those who looked beyond the borders of England to its teeming colonies in the East. India and China, in particular, were popular with the burgeoning publishing industry, from the end of the 19th and well into the 20th century. The choice of India was made to nurture a growing market, developed earlier by the introduction of English education by Lord Macaulay in 1835.

Longman Green set up shop in 1895, while MacMillan and Oxford University Press (OUP) opened offices in Bombay in 1912. For OUP, at least, its arrival in India was equivalent to its rebirth. In the early years of the twentieth century, OUP, the worlds second oldest publishing house, was tottering on the verge of collapse. It had become a press that had increasingly come to embody carelessness (glaring errors and typos were a stock in trade for OUP), bureaucratic decay and corruption. It was largely alive due to its leasing of its printed Bibles and prayer-books.

Its managers at the time, of whom Rieu was one, were uncomfortably aware that in order to survive at all, OUP would have to diversify. Directors at OUP had earlier entered into a joint venture with Hodder and Stoughton to expand into education, science, medicine and fiction. Now, they looked eastwards.

In 1911, then, the British poet, classicist, publisher and translator, Emile Victor Rieu boarded the Trans-Siberian Railway. He was bound first for Shanghai, where OUP wanted its agent sacked for poor service. His next, more, permanent port of call was Bombay. From its first office on Hornby Road, Rieu focused on the advantage that Macaulays Minutes had given OUP, by working to expand business in the area of school textbooks. Indeed, one of the first academic books OUP published at this point was The Essentials of Psychology, written by a young unknown, by the name of Sarvepalli Radhakrishnan. Then, the world went to war.

In India, the first effects that OUP felt were delays and disruptions in shipping. Paper shortages were next, followed by a disastrous non-delivery of important electrotype and stereotype plates that were required for printing. This was topped by a dire lack of hands as the staff were called up to serve on battlefronts across the world. Still, OUP persevered and in 1915, it secured a crucial contract to print textbooks for schools in the Central Provinces.

The contract kept OUP afloat for the duration of the war, and just as well, because by 1917, Rieu couldnt put off his enlistment any longer. He went to war, leaving OUP in the hands of his wife, Nellie, herself the editor of the British literary journal, Athenaeum. She managed by taking orders to print political propaganda for the Government of India. At one point, OUPs non-governmental printing in India was down to a meagre thirty pages. But it held on.

In the aftermath of the war, the Spanish flu visited India, killing millions. Rieu himself returned, having been struck by illness in the midst of action. His most pressing problem (aside, of course, from his recovery) was to relocate OUPs offices immediately. Even despite the war, and the flu, OUP had outgrown its space on Hornby Road. A new space was found on Elphinstone Circle (Horniman Circle, in modern Mumbai): big enough to hold new stocks of books, and an indolent cow that refused to move.

Over the years, OUP has continued to survive, adapting itself to the changing political climate and social needs of the continent with remarkable ease. By the late 1920s, OUPs stock inventories in Madras, Calcutta and Bombay were sizeable and trade was flourishing. It also began putting forth feelers across East and Southeast Asia, in North America and in South America. Today, of course, Oxford University Press is synonymous with more serious works of non-fiction, of education, medicine, history and science: yet another testament to the human ingenuity that is at the heart of the publishing world.

There are innumerable examples from the world of publishing both in terms of big houses and smaller initiatives that stand out against the backdrop of unspeakable strife. Wars, pandemics, global depressions: each a defining crossroads in human history; each with the ability to change life as we know it forever. And yet, the power of the written word transcends disaster of any kind, in its ability to adapt, to survive, to question and to persist.

This series of articles on the impact of the coronavirus pandemic on publishing is curated by Kanishka Gupta.

Continue reading here:

Mass publishing has a history of coping with pandemics. After all, it was born of one - Scroll.in

Tech Stocks Have Been the Markets Stars. Are They Overbought? – Barron’s

Posted on by

Angela Weiss/AFP via Getty Images

Text size

Like an Escher drawing hanging in a students dorm room, the stock market has begun to look rational and irrational simultaneously. Nowhere is that more obvious than in the Nasdaq Composite.

The tech-heavy index has gained 18% this year, after practically ignoring the explosion of Covid-19 cases in places like Florida and Texas. It ended the week with three consecutive highs, and for good reason: The index is composed of the kinds of companies that can not only survive, but thrive, in a world where going about your normal, everyday business could get you sick.

Yet there comes a point when even the soundest argument starts to sound specious, even to those making it, and that seems to be what is happening now. Deutsche Bank analyst Jeriel Ong went on record with his worries about Apples (ticker: AAPL) rally, yet left his Buy rating intact and raised his price target to $400 from $380. Others warn that the big tech stocks are getting expensive and crowded, yet see no alternative when future economic growthand corporate profitscould be impaired. I compare the current environment to the Twilight Zone, says Ed Yardeni of Yardeni Research. There are so many possible ways this could go.

For now, though, it seems to only go upand there may be more to this than fundamental strength. Chris Harvey, U.S. equity strategist at Wells Fargo Securities, notes that when the Russell 1000 Growth index was rebalanced on June 26, the combined share of Apple, Microsoft (MSFT), and Amazon.com (AMZN) rose from 25.3% of the index to 28.6%. Just getting to an index weight required a lot of buyingand most active mutual-fund managers were underweight. With those stocks among the years best performers, it meant managers would underperform the growth index by even more unless they started buying.

While the shift toward the biggest techs is most pronounced in the Russell 1000, most indexes are seeing the same. At Thursdays close, technology made up 28% of the S&P 500, up from 21.5% on Nov. 8, 2016, when the Real Estate sector debuted. The Communications Services sector, which includes Facebook (FB), Alphabet (GOOGL), and Netflix (NFLX), has increased to 11.1% from 2.5%.

Economically sensitive sectors have stayed about the same, and are largely immaterialmaterials, utilities, and real estate have 2.5%, 3%, and 2.8% weightings, respectivelyor seen their shares decline. Energy has fallen from a 7.2% weighting to 2.5%, while Financials have dipped to 9.7% from 13.4%.

A friend wondered only half-jokingly how long it would take for the SPDR S&P 500 exchange-traded fund (SPY) to have the same weightings as the Invesco QQQ ETF (QQQ), which tracks the Nasdaq 100. But it is also clear how reliant the market is on the tech stocks in the Nasdaq for further gainsand how that could lead to future losses. Its a conundrum for investors, who know they are in the same trade together, says Nordea strategist Sebastien Galy.

Like it or not, were all tech investors now.

Write to Ben Levisohn at Ben.Levisohn@barrons.com

The rest is here:

Tech Stocks Have Been the Markets Stars. Are They Overbought? - Barron's

Stock market rising on the indispensable companies – Minneapolis Star Tribune

Posted on by

The boomers and Xers remember when Microsoft was so dominant that a federal judge ordered it broken up.

That year of peak Microsoft was 2000, the tail end of the dot-com boom. While the company stayed in one piece and moved on, 10 years later its stock price was nowhere near its peak. It became easy to never think of Microsoft except maybe when upgrading to the new Office software suite.

But, of course, peak Microsoft really came last week.

Its also the era of peak Apple, peak Amazon.com and peak Netflix.

These companies are worth so much in the stock market now that their big year has become one explanation for a booming stock market rally since March, when a sharp downturn due to the coronavirus pandemic reversed course.

This might not be a stock market story, either, explained away by factors like bored sports bettors looking for a new way to squander their money. Maybe instead we are seeing more value in companies that provide the stuff that turned out to be essential as the COVID-19 pandemic rolls on, and maybe even well after it winds down.

Microsoft often seems surprising on a list of high-flyers, because it must be well into its sleepy, late middle age by now, right? It has been a quarter-century since release of its groundbreaking Windows 95 operating system for personal computers.

After months of ignoring news of its resurgence, it took less than an hour of reading to see its a genuine powerhouse. It provides an array of software and services that form part of the basic foundation for business, stepping into the kind of role once played by International Business Machines Corp.

Microsoft reported revenue of about $35 billion in its last quarter, up 15% from the prior years quarter, with an operating margin of better than 37%. It generated cash flow from operations in just those three months of $17.5 billion.

Microsoft has been battling for top spot among Americas most valuable companies with Amazon and Apple. Yet because of the structure of its ownership, Microsoft is the biggest factor now in how well the S&P 500 performs and thus our perception of the stock market.

The S&P 500 is a weighted index, so the relative value of the components matters a lot. The heavyweight champ Microsoft outweighs the top 10 Minnesota-based companies, combined as a group, by more than two to one.

Take a Minnesota blue-chipper like Target, a corporate stalwart thats a big part of the states economy. Microsoft has more than 25 times the impact of Target in the S&P 500. Microsoft shares go up in price 5%, and that could be enough to make it a good day in the stock market. Target stock goes up 5% and the needle may not budge.

Valuable, not overvalued

This isnt just a Microsoft story, either. Microsoft stocks strong appreciation this year has trailed Netflix and Amazon. As of last week, just six big technology companies now make up about a quarter of the S&P 500.

These big technology companies are still not wildly overvalued, at least according to strategist Jim Paulsen from the Minneapolis-based Leuthold Group, nothing like technology firms were during the frenzied speculation that powered Microsoft (and even a few comically speculative startups) to new highs 20 years ago.

Moreover, he explained, the professional investors are buying them now because they appear safer to own in a really stressful time, kind of like how fund managers bought the stock of utilities or food companies in an earlier era. As he put it, The rally in tech and new-era is being driven at least in part by bearishness and fear.

What made those old-fashioned defensive companies attractive in a sinking economy is that their businesses held up better because nobody voluntarily cut off their own electric power or quit buying groceries. These things are indispensable.

And thats the word that Gene Munster, analyst and co-founder of venture firm Loup Ventures in Minneapolis, used to describe the tools and products that companies like Microsoft and Apple now sell.

You may not love these companies, their market dominance and hubris, but they do really deliver. Social isolation and working from home made Apples iPhones and iPads as important as a working refrigerator. Need a computer mouse right away because a teenager borrowed one that then went missing? Try Amazon.com.

There are competitors in streaming video including Apple and Walt Disney Co., but Netflix is the cant-miss place for entertainment this year.

Last weekend our family used Netflix to watch a new movie about a comically bad Icelandic musical duo. The movie was fine, but what made this a memorable evening was how five family members could watch one movie together, chatting away, from four different living rooms.

I dont know how much Netflix would have to raise its price to get me to cancel.

Whats essential?

Facebook has been another strong performer of late, yet Munster called it an outlier to his notion of the top firms providing essential services.

Hes not referring to the swelling controversy over Facebooks content algorithms and hate speech. He just cant easily see what its next big opportunity is.

These big technology companies have likely become too important for regulators to ignore, and unwelcome changes for them may lie ahead. But to Munster the winners both provide something essential now and will probably keep doing that as needs rapidly evolve.

How people work five years from now is going to look very similar to the way we worked during the pandemic, Munster said, and employers likely will want all the necessary tools in one package to enable that to work. Microsoft, he said, is in a position to do that.

Even now, counting up the services or products from Microsoft I use took more than the fingers of one hand. Theres writing with Microsoft Word on a Microsoft keyboard, retrieving documents stored in the cloud on OneDrive and connecting with colleagues through the video conferencing and messaging service called Teams.

When Monday morning comes and the mouse is clicked to get into OneDrive, it really needs to work.

And it will.

Read more from the original source:

Stock market rising on the indispensable companies - Minneapolis Star Tribune

Why are so many doubters unable to leave faith? Watch and read. – Patheos

Posted on by

Alisa Childers is a singer, author and podcaster who is clearly extraordinarily intelligent and perceptive.

Yet, she is also a devout Christian who very nearly left the faith altogether due to fundamental rational doubts but ultimately found her way back by re-embracing reconstructing, in regressive Christian parlance the airy, subjective justifications of supernatural faith she originally held dear.

She did this by effectively ignoring all the excellent objective questions against her faith and focusing instead on the sacredness of historical Christianity and the saving qualities of spiritual grace, and other elements of that self-justifying, excuse-offering branch of Christian theology known as apologetics, or scholasticism.

I had never heard of Childers before the other day, but I was fascinated (in disturbing ways) while watching a nearly 52-minute interview with her conducted by host Cameron Bertuzzi of YouTubes Capturing Christianity site, whose tag line is, BTW, Christianity is true.

From there, I watched on Childerswebsite the 5-minute explanatory video My Story about her authentic Christian fundamentalist upbringing, her budding doubt, semi-deconstruction and then final, reconstructive return to faith.

I also watched her disarmingly interesting 54-minute interview with fellow deconstructed/reconstructed apologist Ian Harbor, in which he encapsulated his long journey away from and back to historical Christianity ostensibly the original faith as a necessary mental exercise of just choosing to believe what the Bible says is absolutely true, doubt aside.

From this interview, I chose to read Harbors article in TGC (The Gospel Coalition), an online Christian media site. This is his disappointing (to rationalists) conclusion in the piece:

There are more paths than ever before in todays worldmore options for spiritual enlightenment or curate-your-own-beliefs faith. But no path leads to true happiness and everlasting life except the Jesus alone path (John 14:6), which is narrower than we might like (Matt. 7:13) but more satisfying than we can imagine (Ps. 16:11).

In my journey I discovered, with Peter, thatGods divine power has granted to us all things that pertain to life and godliness, through the knowledge of him who called us to his own glory and excellence(2 Peter 1:3). In Christ, we have everything we need. Why leave the boundaries of faith once for all delivered to the saints (Jude 1:3) in order to find life? Jesus has the words of life.Heislife. Truth. The way.Where else would we go?

Harbor wrote of arrive at his post-doubt final destination, which wasexactly the same place he started out in faith:

Ive walked in both shoes: the shoes of those who deserted (the faith) and the shoes of (Saint) Peter who couldnt leave, no matter how hard it seemed to stay.

He chose the latter.

I keep reading about devout Christians whose theological questions become so grave that they seriously doubt the core tenets of their faith, yet they still find it impossible to ultimately abandon Christianity. Youd think it wouldnt disturb me anymore, as often as it happens, considering many, many ex-Christians have been able to break free of the chains of dogma and supernatural belief. But it does, because its a willful, self-deceiving capitulation to irrationality, trading fantasy for the necessities of fact.

But surveys consistently tell us that, up to now, the majority of Americans view themselves a God-believing Christians. So, we need to try to understand this strange phenomenon of seemingly groundless faith in omnipotent deities that permanently resists verification.

If you want to better understand this clinging-to-faith tendency, I strongly urge you to watch some or all of these videos, and Ian Harbors well-written if dubiously reasoned article, all linked above.

Whats frightening to me is that Childers and Harbor both obviously very intelligent, thoughtful and articulate spokespeople for their faith have chosen to simply ignore objective reality so they dont have to throw out the baby Jesus of their beliefs with the dirty bathwater doubt leaves behind.

Its fundamentally disingenuous, but Im sure it doesnt feel that way to them, because they truly believe.

Videos/YouTube/Alisachilders.com

Buy either book on Amazon, here (paperback or ebook editions)

Visit link:

Why are so many doubters unable to leave faith? Watch and read. - Patheos

On Guru Purnima, Shilpa Shetty, Sanjay Dutt and other Bollywood stars pay tribute to their teachers – Free Press Journal

Posted on by

Bollywood stars including Sanjay Dutt, Shilpa Shetty Kundra and Randeep Hooda on Sunday paid tribute to teachers, on the occasion of Guru Purnima.

The 'Panipat' star put out a heart-warming post on Twitter featuring a monochromatic throwback picture of parents Sunil and Nargis Dutt as he remembered them as his gurus (teachers). In the picture, Sanjay is seen standing next to his father while the latter smiles. The frame also captures 'Mother India' star Nargis who is seen embracing her beaming smile.

Along with the picture, the 'Agneepath' star shared an emotional note, and noted, "Even though my parents are not here with me today, but their blessings and teachings will always remain with me. They have been my very first teachers, guiding my every step in life. #HappyGuruPurnima to all." (with a folded hands emoji)

See the original post here:

On Guru Purnima, Shilpa Shetty, Sanjay Dutt and other Bollywood stars pay tribute to their teachers - Free Press Journal

Global Blockchain Technology Industry – GlobeNewswire

Posted on by

New York, July 10, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Blockchain Technology Industry" - https://www.reportlinker.com/p05443600/?utm_source=GNW 5 Billion by 2027, growing at a CAGR of 64.2% over the analysis period 2020-2027.Public, one of the segments analyzed in the report, is projected to grow at a 65.4% CAGR to reach US$96.2 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Private segment is readjusted to a revised 62.7% CAGR for the next 7-year period. This segment currently accounts for a 24.6% share of the global Blockchain Technology market.

The U.S. Accounts for Over 30.6% of Global Market Size in 2020, While China is Forecast to Grow at a 60.9% CAGR for the Period of 2020-2027 The Blockchain Technology market in the U.S. is estimated at US$1.4 Billion in the year 2020. The country currently accounts for a 30.61% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$22.1 Billion in the year 2027 trailing a CAGR of 60.9% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 57.5% and 54.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 43.1% CAGR while Rest of European market (as defined in the study) will reach US$22.1 Billion by the year 2027.

Hybrid Segment Corners a 11.2% Share in 2020 In the global Hybrid segment, USA, Canada, Japan, China and Europe will drive the 60.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$396.7 Million in the year 2020 will reach a projected size of US$10.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$17.7 Billion by the year 2027.We bring years of research experience to this 15th edition of our report. The 311-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

-Competitors identified in this market include, among others,

Read the full report: https://www.reportlinker.com/p05443600/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW Blockchain, The Technological Essence of Bitcoin, Emerges to Disrupt the Digital Economy The Promise of Decentralized Internet Moving Beyond Bitcoin Revolutionizing Benefits of Blockchain that Double Up as Powerful Growth Drivers Decentralized Database, Immutability, Encrypted Blocks and Elimination of Intermediaries - Inimitable Benefits of Blockchain Technology to Propel Market Growth The Three Generations of Blockchain Technology Recent Market Activity Asia-Pacific to Spearhead Growth in Blockchain Technology Sphere While Financial Services Sector Leads Blockchain Applications, Non-Finance Sectors Look to Catch-up with Investigational Blockchain-based Initiatives Next-Generation Blockchain Innovations to Foster Development of New Applications While Finance Industry Leads, Non-Finance Sectors Present Long -term Potential Public Blockchain Networks Dominate Market Revenues Global Competitor Market Shares Blockchain Technology Competitor Market Share Scenario Worldwide (in %): 2020 & 2029 Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS AlphaPoint Corporation (USA) Blockchain Global (Australia) Blockchain Tech Ltd (Canada) BlockCypher, Inc. (USA) Bloq (USA) Chain, Inc. (USA) Coinfirm Ltd. (UK) Consensus Systems (USA) Credits (UK) Digital Asset Holdings, LLC (USA) IBM (USA) LUKKA, INC. (USA) Microsoft Corporation (USA) Monax Industries (UK) Nasdaq (USA) ShoCard (USA) The Bitfury Group (USA) The Linux Foundation (USA)

3. MARKET TRENDS & DRIVERS Noteworthy Trends & Issues Widening Network of IoT Systems to Power Blockchain Implementations Blockchain Assumes Critical Role as a Tool for Enabling Financial Inclusion of the Unbanked Venture Capitalists Flock to Fund Blockchain Companies: An Indication of the High Growth Potential of Blockchain Technology Blockchain-as-a Service (BaaS): Outsourcing the Implementation and Management of Blockchain-based Platforms Smart Contracts: Among the Most Promising Use Cases of Distributed Ledger Technology Emerging Trends in the Blockchain Technology Landscape Combination of AI and Blockchain - Focus on Development Initiatives Blockchain Technology Emerges to Mitigate Issues Impeding Deployment of IoT Promising Innovations to Facilitate Further Advancements in Blockchain Technology Though Built Originally for Bitcoin, Innovative Applications Set to Transform Blockchain Market Industry-wide Collaborations: Critical for Developing Practical Applications of Blockchain Existing Regulatory Framework & Infrastructure Limitations Impede Wider Adoption of Blockchain Technology

4. GLOBAL MARKET PERSPECTIVE Table 1: Blockchain Technology Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027

Table 2: Blockchain Technology Market Share Shift across Key Geographies Worldwide: 2020 VS 2027

Table 3: Public (Type) World Market by Region/Country in US$ Thousand: 2020 to 2027

Table 4: Public (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027

Table 5: Private (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027

Table 6: Private (Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027

Table 7: Hybrid (Type) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027

Table 8: Hybrid (Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027

Table 9: Financial Services (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027

Table 10: Financial Services (Application) Share Breakdown Review by Region/Country: 2020 VS 2027

Table 11: Telecom & Media (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027

Table 12: Telecom & Media (Application) Distribution of Global Sales by Region/Country: 2020 VS 2027

Table 13: Transportation (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027

Table 14: Transportation (Application) Global Market Share Distribution by Region/Country for 2020 and 2027

Table 15: Healthcare (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027

Table 16: Healthcare (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027

Table 17: Other Applications (Application) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027

Table 18: Other Applications (Application) Market Share Shift across Key Geographies: 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES Market Facts & Figures US Blockchain Technology Market Share (in %) by Company: 2020 & 2025 Market Analytics Table 19: United States Blockchain Technology Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027

Table 20: United States Blockchain Technology Market Share Breakdown by Type: 2020 VS 2027

Table 21: United States Blockchain Technology Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027

Table 22: Blockchain Technology Market Share Breakdown in the United States by Application: 2020 VS 2027

CANADA Table 23: Canadian Blockchain Technology Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027

Table 24: Blockchain Technology Market in Canada: Percentage Share Breakdown of Sales by Type for 2020 and 2027

Table 25: Canadian Blockchain Technology Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027

Table 26: Canadian Blockchain Technology Market Share Analysis by Application: 2020 VS 2027

JAPAN Table 27: Japanese Market for Blockchain Technology: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027

Table 28: Japanese Blockchain Technology Market Share Analysis by Type: 2020 VS 2027

Table 29: Japanese Demand Estimates and Forecasts for Blockchain Technology in US$ Thousand by Application: 2020 to 2027

Table 30: Blockchain Technology Market Share Shift in Japan by Application: 2020 VS 2027

CHINA Table 31: Chinese Blockchain Technology Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027

Table 32: Chinese Blockchain Technology Market by Type: Percentage Breakdown of Sales for 2020 and 2027

Table 33: Chinese Demand for Blockchain Technology in US$ Thousand by Application: 2020 to 2027

Table 34: Chinese Blockchain Technology Market Share Breakdown by Application: 2020 VS 2027

EUROPE Market Facts & Figures European Blockchain Technology Market: Competitor Market Share Scenario (in %) for 2020 & 2025 Market Analytics Table 35: European Blockchain Technology Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025

Table 36: European Blockchain Technology Market Share Shift by Region/Country: 2020 VS 2027

Table 37: European Blockchain Technology Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027

Table 38: European Blockchain Technology Market Share Breakdown by Type: 2020 VS 2027

Table 39: European Blockchain Technology Addressable Market Opportunity in US$ Thousand by Application: 2020-2027

Table 40: European Blockchain Technology Market Share Analysis by Application: 2020 VS 2027

FRANCE Table 41: Blockchain Technology Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027

Table 42: French Blockchain Technology Market Share Analysis by Type: 2020 VS 2027

Table 43: Blockchain Technology Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027

Table 44: French Blockchain Technology Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027

GERMANY Table 45: Blockchain Technology Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027

Table 46: German Blockchain Technology Market Share Breakdown by Type: 2020 VS 2027

Table 47: Blockchain Technology Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027

Table 48: Blockchain Technology Market Share Distribution in Germany by Application: 2020 VS 2027

ITALY Table 49: Italian Blockchain Technology Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027

Table 50: Italian Blockchain Technology Market by Type: Percentage Breakdown of Sales for 2020 and 2027

Table 51: Italian Demand for Blockchain Technology in US$ Thousand by Application: 2020 to 2027

Table 52: Italian Blockchain Technology Market Share Breakdown by Application: 2020 VS 2027

UNITED KINGDOM Table 53: United Kingdom Market for Blockchain Technology: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027

Table 54: United Kingdom Blockchain Technology Market Share Analysis by Type: 2020 VS 2027

Table 55: United Kingdom Demand Estimates and Forecasts for Blockchain Technology in US$ Thousand by Application: 2020 to 2027

Table 56: Blockchain Technology Market Share Shift in the United Kingdom by Application: 2020 VS 2027

REST OF EUROPE Table 57: Rest of Europe Blockchain Technology Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027

Table 58: Rest of Europe Blockchain Technology Market Share Breakdown by Type: 2020 VS 2027

Table 59: Rest of Europe Blockchain Technology Addressable Market Opportunity in US$ Thousand by Application: 2020-2027

Table 60: Rest of Europe Blockchain Technology Market Share Analysis by Application: 2020 VS 2027

ASIA-PACIFIC Table 61: Blockchain Technology Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027

Table 62: Asia-Pacific Blockchain Technology Market Share Analysis by Type: 2020 VS 2027

Table 63: Blockchain Technology Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027

Table 64: Asia-Pacific Blockchain Technology Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027

REST OF WORLD Table 65: Rest of World Blockchain Technology Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027

Table 66: Blockchain Technology Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2020 and 2027

Table 67: Rest of World Blockchain Technology Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027

Table 68: Rest of World Blockchain Technology Market Share Analysis by Application: 2020 VS 2027

IV. COMPETITION

Total Companies Profiled: 119Read the full report: https://www.reportlinker.com/p05443600/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Read more:

Global Blockchain Technology Industry - GlobeNewswire

Global Black Cumin Seed Oil Market Growth is Projected to Grow at Sluggish Rate by 2027 Post COVID 19 Pandemic Henry Lamotte OILS GmbH, FLAVEX…

Posted on by

Global Black Cumin Seed Oil Market analysis 2015-2027, is a research report that has been compiled by studying and understanding all the factors that impact the market in a positive as well as negative manner. Some of the prime factors taken into consideration are: various rudiments driving the market, future opportunities, restraints, regional analysis, various types & applications, Covid-19 impact analysis and key market players of the Black Cumin Seed Oil market. nicolas.shaw@cognitivemarketresearch.com or call us on +1-312-376-8303.

Download Report from: https://cognitivemarketresearch.com/food-%26-beverages/black-cumin-seed-oil-market-report

Global Black Cumin Seed Oil Market: Product analysis: Food Grade, Cosmetic Grade

Global Black Cumin Seed Oil Market: Application analysis: Soap, Health Food, Personal Care Products (Massage Oils Skin Care Products)

Major Market Players with an in-depth analysis: Henry Lamotte OILS GmbH, FLAVEX Naturextrakte GmbH, Henry Lamotte Oils GmbH, Kerfoot Group, Earthoil Plantations, Life Extension, Nuverus, Omega Pharma, BioPraep

The research is presented in such a way that it consists of all the graphical representations, pie charts and various other diagrammatic representations of all the factors that are used for the research. Black Cumin Seed Oil market research report also provides information on how the industry is anticipated to provide a highly competitive analysis globally, revenues generated by the industry and increased competitiveness and expansions among various market players/companies.

Get A Free Sample of Black Cumin Seed Oil Market Report: https://cognitivemarketresearch.com/food-%26-beverages/black-cumin-seed-oil-market-report#download_report

The Black Cumin Seed Oil industry is projected in assembling information regarding dynamic approximations and also listings of a profitable progression rate annually in the expected duration according to a recent & latest study. The latest Coronavirus pandemic impact along with graphical presentations and recovery analysis is included in the Black Cumin Seed Oil research report. The research report also consists of all the latest innovations, technologies and systems implemented in the Black Cumin Seed Oil industries.

Various factors with all the necessary limitations, expenditure/cost figures, consumer behaviour, supply chain, government policies and all the information related to the market have been included in the Black Cumin Seed Oil Market report. The research report also provides light on various companies & their competitors, market size & share, revenue, forecast analysis and all the information regarding the Black Cumin Seed Oil Market.

Checkout Inquiry for Buying or Customization of Report: https://cognitivemarketresearch.com/food-%26-beverages/black-cumin-seed-oil-market-report#download_report.

Black Cumin Seed Oil Market research report provides an in-depth analysis of the entire market scenario starting from the basics which is the market introduction till the industry functioning and its position in the market as well as all the projects and latest introductions & implementations of various products. The research study has been assembled by understanding and combining various analysis of regions globally & companies and all necessary graphs and tables that bring the theory into an exact representation through numerical values and standard tables.

The global estimations of the market value, market information/definition, classifications of all the types & applications, overall threats & dips that can be assumed and many other factors which consist the overall market scenario and its happening globally along with the forthcoming years are compiled in the Black Cumin Seed Oil market research report. Hence this report can serve as a handbook/model for the enterprises/players interested in the Black Cumin Seed Oil Market as it consists all the information regarding the Black Cumin Seed Oil market.

Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample): Click Here>Download Sample Report of Black Cumin Seed Oil Market Report 2020 (Coronavirus Impact Analysis on Black Cumin Seed Oil Market)

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.(*If you have any special requirements, please let us know and we will offer you the report as you want.)

About Us: Cognitive Market Research is one of the finest and most efficient Market Research and Consulting firm. The company strives to provide research studies which include syndicate research, customized research, round the clock assistance service, monthly subscription services, and consulting services to our clients. We focus on making sure that based on our reports, our clients are enabled to make most vital business decisions in easiest and yet effective way. Hence, we are committed to delivering them outcomes from market intelligence studies which are based on relevant and fact-based research across the global market.Contact Us: +1-312-376-8303Email: nicolas.shaw@cognitivemarketresearch.comWeb: https://www.cognitivemarketresearch.com/

**********Download the Entire Report*************************************************https://cognitivemarketresearch.com/food-%26-beverages/black-cumin-seed-oil-market-report

Follow this link:

Global Black Cumin Seed Oil Market Growth is Projected to Grow at Sluggish Rate by 2027 Post COVID 19 Pandemic Henry Lamotte OILS GmbH, FLAVEX...

COVID-19 Impact on Infusion Extension Lines Market 2020: Global Industry Trends, Growth Opportunities, SWOT Analysis by Top Key Players and Forecast…

Posted on by

Global Infusion Extension Lines Market presents insights into the present and upcoming industry trends, enabling the readers to identify the products and services, hence driving the enlargement and effectiveness. The research report provides a comprehensive breakdown of all the major factors impacting the market on a global and regional scale, including drivers, constraints, intimidation, challenges, opportunities, and industry-specific trends. Further, the report cites global certainties and endorsements along with downstream and upstream analysis of leading players.

Get more information on Global Infusion Extension Lines Market Research Report by requesting FREE Sample Copy @ https://www.globalmarketers.biz/report/life-sciences/2015-2027-global-infusion-extension-lines-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/147205#request_sample

Major Players:

RontisFresenius KabiSarstedtBicakcilarVygon (UK)Bionic Medizintechnik

Global Infusion Extension Lines Market research reports enlargement rates and the market value based on market dynamics, growth factors. Complete knowledge is based on the newest innovation in business, opportunities, and trends. In addition to SWOT examination by key suppliers, the report contains an all-inclusive market analysis and major players landscape.

The regional segmentation covers:

Segmentation by Type:

Spiral-LineSmall Bore Connection TubingOther

Segmentation by Application:

HospitalClinic

Do Inquiry Before Purchasing Report Here and Ask For Discount @: https://www.globalmarketers.biz/discount_inquiry/discount/147205

Report Objectives

Enquire Before Buying : https://www.globalmarketers.biz/report/life-sciences/2015-2027-global-infusion-extension-lines-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/147205#inquiry_before_buying

Table of Content:

The Global Infusion Extension Lines Market

Chapter 1: Infusion Extension Lines Market Overview, Drivers, Restraints and Opportunities

Chapter 2: Infusion Extension Lines Market Competition by Manufacturers

Chapter 3: Infusion Extension Lines Production by Regions

Chapter 4: Production, By Types, Market share by Types

Chapter 5: Consumption, By Applications

Chapter 6: Comprehensive profiling and analysis of Manufacturers

Chapter 7: Manufacturing cost analysis

Chapter 8: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 9: Marketing Strategy Analysis, Distributors/Traders

Chapter 10: Infusion Extension Lines Market Effect Factors Analysis

Chapter 11: Infusion Extension Lines Market Forecast

Chapter 12: Conclusion of Infusion Extension Lines Market

The Report has Tables and Figures Browse The Report Description and TOC @ https://www.globalmarketers.biz/report/life-sciences/2015-2027-global-infusion-extension-lines-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/147205#table_of_contents

Read more here:

COVID-19 Impact on Infusion Extension Lines Market 2020: Global Industry Trends, Growth Opportunities, SWOT Analysis by Top Key Players and Forecast...